Rentosertib is designed to treat IPF by targeting Traf2- and NCK-interacting kinase (TNIK), a serine/threonine kinase whose activation plays a crucial role in cellular processes that include signal ...

Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...

Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with a weakened ...

THR-beta agonists are the only medication approved to treat metabolic dysfunction–associated steatohepatitis (MASH), a severe form of liver disease. Learn more.

New water-soluble galectin antagonist being considered in preclinical trials offering hope for rapid containment to H5N1 outbreaksBOSTON, ...

Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025Denifanstat received Breakthrough Therapy ...

Sawyer Hawks, a Vanderbilt baseball transfer, is guided by his late mother's memory and by the community that helped raise ...

A recent study published on January 31, 2024, in Nature Aging introduces a potential new drug that could help. Scientists believe this drug can remove harmful “zombie” cells from the liver and slow ...

Recent findings from the RESOLVE-1 trial highlight mycophenolate mofetil's efficacy in treating diffuse cutaneous systemic ...

StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a research note issued to investors on Tuesday. The firm issued a sell rating on the biotechnology company’s ...

Trevi Therapeutics (NASDAQ:TRVI – Get Free Report) will likely be announcing its earnings results before the market opens on ...